RxDoctor Payments Data

Robin Fuller, APRN

Nurse Practitioner · Waterville, MENPI 1124655519

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.1% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Harmony Biosciences LLC at 48.2% of the total. 2025 is the largest year on record at $1,041, 2.2 times the $473 reported in 2022. Among nurse practitioner clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,784in general payments, 2019–2025

Across 56 payments — averaging $31.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Harmony Biosciences LLC$861
  • Jazz Pharmaceuticals Inc.$359
  • Avadel CNS Pharmaceuticals, LLC$205
  • Axsome Therapeutics, Inc.$132
  • Takeda Pharmaceuticals U.S.A., Inc.$125
  • Inspire Medical Systems, Inc.$69
  • plus $33 from 2 others

What the payments were for

  • Food & beverage$1,64492%
  • Education$1408%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,784 in reported general payments places this provider in the 95th percentile of 740 nurse practitioner providers in Maine.

See all nurse practitioner providers in Maine

Medicare billing

Part B allowed, 2024
$10,705
Medicare patients
109
Services billed
156

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Modafinil12$511
Ropinirole Hcl13$106

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Waterville

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →